Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | SVP,ChiefCompliance&EthicsOff. | July 30, 2021 | August 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date July 30, 2021 · Filed August 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 13,777.152 |
Reported balance
After 2021-07-30 transaction · row 1
1 source rowRow 1 · 2021-07-30 · Sale · Disposed 2,466 · Balance 13,777.152 F1: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.905 to $67.910, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | IndirectBMS Savings and Investment Program | 971.87 |
Reported balance
Holding disclosure · report date 2021-07-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 971.87 F2: Based on a plan statement as of the end of the most recent fiscal quarter. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.905 to $67.910, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F2: Based on a plan statement as of the end of the most recent fiscal quarter.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Day One Biopharmaceuticals, Inc.
Report date April 23, 2026 · Filed April 23, 2026
Section 16 reporting ended · disclosed 2026-04-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 1
1 source rowRow 1 · 2026-04-23 · Disposition to issuer · Disposed 72,694 · Balance 0 F1: On March 6, 2026, Servier Pharmaceuticals LLC, a Delaware limited liability company ("Parent"), Servier Detroit Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Day One Biopharmaceuticals, Inc., a Delaware corporation (the "Company"), and Servier S.A.S., a French societe par actions simplifiee, solely as a guarantor, entered into an Agreement and Plan of Merger (the "Merger Agreement"). Pursuant to the Merger Agreement, the Merger Sub merged with and into the Company (such merger and the other transactions contemplated by the Merger Agreement, the "Merger") with the Company surviving the Merger as a wholly owned subsidiary of the Parent. F2: Upon the closing of the Merger on April 23, 2026, each issued and outstanding share of the Company's Common Stock, par value $0.0001 per share, was either (x) purchased for $21.50 per share (the "Offer Price"), net to the seller in cash, without interest, and subject to applicable withholding taxes, on the terms and conditions set forth in the Merger Agreement, or (y) automatically converted into the right to receive the Offer Price (the "Merger Consideration"), net to the seller in cash, without interest, and subject to applicable withholding taxes, on the terms and conditions set forth in the Merger Agreement. |
| Stock Option (right to buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.99 · Expires 2032-10-30 | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-23 · Disposition to issuer · Disposed 309,000 · Balance 0 F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F3: The option vests as to 100% of the total shares on November 6, 2026, subject to the Reporting Person's provision of service to the Issuer on such vesting date. |
| Stock Option (right to buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.99 · Expires 2033-01-16 | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-23 · Disposition to issuer · Disposed 90,000 · Balance 0 F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F5: The option vests as to 1/48th of the total shares monthly, commencing February 17, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| Stock Option (right to buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.99 · Expires 2034-01-04 | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-23 · Disposition to issuer · Disposed 90,000 · Balance 0 F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F6: The option vests as to 1/48th of the total shares monthly, commencing February 5, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| Stock Option (right to buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.99 · Expires 2035-01-14 | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-23 · Disposition to issuer · Disposed 90,000 · Balance 0 F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F7: The option vests as to 1/48th of the total shares monthly, commencing February 15, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| Stock Option (right to buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $11.16 · Expires 2036-01-29 | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-23 · Disposition to issuer · Disposed 105,000 · Balance 0 F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F8: The option vests as to 1/48th of the total shares monthly, commencing February 28, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-23 · Disposition to issuer · Disposed 8,889 · Balance 0 F9: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F10: The Restricted Stock Units ("RSUs") vest as to 25% of the total award on November 15, 2023, and 1/12th of the remaining amount vests in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F11: RSUs do not expire; they either vest or are canceled prior to the vesting date. |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-23 · Disposition to issuer · Disposed 5,250 · Balance 0 F9: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F12: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F11: RSUs do not expire; they either vest or are canceled prior to the vesting date. |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-23 · Disposition to issuer · Disposed 25,816 · Balance 0 F9: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F12: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F11: RSUs do not expire; they either vest or are canceled prior to the vesting date. |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-04-23 · Disposition to issuer · Disposed 40,565 · Balance 0 F9: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F12: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F11: RSUs do not expire; they either vest or are canceled prior to the vesting date. |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-23 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-04-23 · Disposition to issuer · Disposed 65,625 · Balance 0 F9: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes. F12: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F11: RSUs do not expire; they either vest or are canceled prior to the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 6, 2026, Servier Pharmaceuticals LLC, a Delaware limited liability company ("Parent"), Servier Detroit Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Day One Biopharmaceuticals, Inc., a Delaware corporation (the "Company"), and Servier S.A.S., a French societe par actions simplifiee, solely as a guarantor, entered into an Agreement and Plan of Merger (the "Merger Agreement"). Pursuant to the Merger Agreement, the Merger Sub merged with and into the Company (such merger and the other transactions contemplated by the Merger Agreement, the "Merger") with the Company surviving the Merger as a wholly owned subsidiary of the Parent.
F2: Upon the closing of the Merger on April 23, 2026, each issued and outstanding share of the Company's Common Stock, par value $0.0001 per share, was either (x) purchased for $21.50 per share (the "Offer Price"), net to the seller in cash, without interest, and subject to applicable withholding taxes, on the terms and conditions set forth in the Merger Agreement, or (y) automatically converted into the right to receive the Offer Price (the "Merger Consideration"), net to the seller in cash, without interest, and subject to applicable withholding taxes, on the terms and conditions set forth in the Merger Agreement.
F3: The option vests as to 100% of the total shares on November 6, 2026, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
F4: Immediately prior to the effective time of the Merger, all outstanding unvested stock options and unvested restricted stock units became fully vested. At the effective time of the Merger, each stock option and restricted stock unit was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration (or, in the case of stock options, the difference between the Merger Consideration and the applicable per share exercise price), less any applicable withholding taxes.
F5: The option vests as to 1/48th of the total shares monthly, commencing February 17, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F6: The option vests as to 1/48th of the total shares monthly, commencing February 5, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F7: The option vests as to 1/48th of the total shares monthly, commencing February 15, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F8: The option vests as to 1/48th of the total shares monthly, commencing February 28, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F9: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F10: The Restricted Stock Units ("RSUs") vest as to 25% of the total award on November 15, 2023, and 1/12th of the remaining amount vests in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F11: RSUs do not expire; they either vest or are canceled prior to the vesting date.
F12: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2023 Filed Nov 17, 2023 23:30 UTC | Day One Biopharmaceuticals, Inc. DAWN · Entity 51180 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055889 · doc4.xml · derivative · entry 5 Dubow Adam · CIK 0001744507 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 23:30 UTC | Day One Biopharmaceuticals, Inc. DAWN · Entity 51180 | Exercise / conversionRestricted Stock Units · Derivative | 11,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055889 · doc4.xml · derivative · entry 4 Dubow Adam · CIK 0001744507 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,550 Underlying: Common Stock · 11,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vest as to 25% of the total award on November 15, 2023, and 1/12th of the remaining amount vest in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vest as to 25% of the total award on November 15, 2023, and 1/12th of the remaining amount vest in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 23:30 UTC | Day One Biopharmaceuticals, Inc. DAWN · Entity 51180 | Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-055889 · doc4.xml · nonDerivative · entry 2 Dubow Adam · CIK 0001744507 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 23:30 UTC | Day One Biopharmaceuticals, Inc. DAWN · Entity 51180 | Exercise / conversionCommon Stock | 11,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-055889 · doc4.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 20:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 2,466 | $67.90 | $167,441.40 |
DisclosureSEC source: 0000014272-21-000196 · wf-form4_162802414717075.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,777.152 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.905 to $67.910, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 3,119 | $64.21 | $200,270.99 |
DisclosureSEC source: 0000014272-21-000130 · wf-form4_162042102324582.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,243.152 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in two transactions at prices $64.21 and $64.215, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in two transactions at prices $64.21 and $64.215, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 5,972 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 23 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,972 Underlying: Common Stock, $0.10 par value · 5,972 shares Expires 2024-03-10 F14 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2024. F14 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2024. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 22 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,495 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2021, subject to a Total Shareholder Return. F13 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2021, subject to a Total Shareholder Return. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 3,981 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 21 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,981 Underlying: Common Stock, $0.10 par value · 3,981 shares Expires 2025-03-10 F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F12 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 20 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,943 Underlying: Common Stock, $0.10 par value · 980 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 1,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 19 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,124 Underlying: Common Stock, $0.10 par value · 1,062 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 18 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418 Underlying: Common Stock, $0.10 par value · 415 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 452 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · derivative · entry 17 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 452 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2017. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 935 | $60.93 | $56,969.55 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 15 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,362.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 486 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 14 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,297.152 F9 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 13 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,811.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Amount represents distribution of performance shares earned under the 2018-2020 Long-Term Performance Award. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 313 | $60.93 | $19,071.09 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 12 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,316.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 11 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,629.152 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 10 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,611.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 391 | $60.93 | $23,823.63 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 9 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,631.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 8 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,022.152 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 7 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,838.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 119 | $60.93 | $7,250.67 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 6 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,776.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 36 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 5 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,895.152 F5 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 4 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,931.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 152 | $60.93 | $9,261.36 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 3 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,516.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 2 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,668.152 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:59 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 452 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000094 · wf-form4_161559353164001.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,638.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2017. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 900 | $63.39 | $57,051.00 |
DisclosureSEC source: 0000014272-20-000286 · wf-form4_160633992053726.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,186.152 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $63.385 to $63.386, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $63.385 to $63.386, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2020 Filed May 26, 2020 21:17 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 3,200 | $61.01 | $195,232.00 |
DisclosureSEC source: 0000014272-20-000173 · wf-form4_159052780720866.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,086.152 Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 5,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 23 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,885 Underlying: Common Stock, $0.10 par value · 5,885 shares Expires 2023-03-10 F14 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2023. F14 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2023. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 2,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 22 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,707 shares Expires 2020-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2020, subject to a Total Shareholder Return. F13 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2020, subject to a Total Shareholder Return. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 3,923 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 21 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,923 Underlying: Common Stock, $0.10 par value · 3,923 shares Expires 2024-03-10 F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F12 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 1,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 20 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,186 Underlying: Common Stock, $0.10 par value · 1,062 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 19 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 Underlying: Common Stock, $0.10 par value · 415 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 451 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 18 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452 Underlying: Common Stock, $0.10 par value · 451 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2017. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · derivative · entry 17 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 372 shares Expires 2020-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2016. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,077 | $57.93 | $62,390.61 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 15 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,286.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 272 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 14 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,363.152 F9 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 13 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,091.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Amount represents distribution of performance shares earned under the 2017-2019 Long-Term Performance Award. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 470 | $57.93 | $27,227.10 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 12 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 11 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,854.152 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 10 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,616.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 143 | $57.93 | $8,283.99 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 9 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,554.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 8 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,697.152 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 7 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,717.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 182 | $57.93 | $10,543.26 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 6 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,302.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 5 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,484.152 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 451 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 4 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,433.152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2017. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 133 | $57.93 | $7,704.69 |
DisclosureSEC source: 0000014272-20-000116 · wf-form4_158405115682878.xml · nonDerivative · entry 3 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,982.152 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.